NASDAQ: MIST
Milestone Pharmaceuticals Inc Earnings Dates, Reports, Calls

Milestone Pharmaceuticals earnings were -$41.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MIST earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$12.4M, up 31% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MIST reported annual earnings of -$41.5M, with -30.4% growth. The next MIST earnings date is May 12, 2025.

MIST earnings history

Current Revenue
$0.0
Current Earnings
-$41.5M
Current Profit Margin
0%

MIST Return on Equity

Current Company
-152.3%
Current Industry
-2%
Current Market
34.1%
MIST's Return on Equity (-152.3%)... subscribe to Premium to read more.
High Return on Equity Performance

MIST undefined

Current Company
-48.4%
Current Industry
-0.4%
MIST is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MIST announces earnings.

MIST undefined

Current Company
-56.31%
Current Industry
5.9%
MIST's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MIST vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MIST-$37.83M-$41.52MN/A-$0.67
DTIL$13.53M$7.17MN/A$1.05
BYSI-$10.74M-$11.12MN/A-$0.28
MDCX-$11.18M-$11.16MN/A-$1.16
IKNA-$46.54M-$49.23MN/A-$1.02

MIST earnings dates

Next earnings date
May 12, 2025

Milestone Pharmaceuticals Earnings Reports & History FAQ

What were Milestone Pharmaceuticals's earnings last quarter?

On MIST's earnings call on Invalid Date, Milestone Pharmaceuticals (NASDAQ: MIST) reported Q4 2024 earnings per share (EPS) of -$0.19, up 40.63% year over year. Total MIST earnings for the quarter were -$12.36 million. In the same quarter last year, Milestone Pharmaceuticals's earnings per share (EPS) was -$0.32.

If you're new to stock investing, here's how to buy Milestone Pharmaceuticals stock.

When does Milestone Pharmaceuticals report earnings?

The next MIST earnings call is Invalid Date. Add MIST to your watchlist to be reminded of Milestone Pharmaceuticals's next earnings date.

What was MIST's earnings growth in the past year?

As of Milestone Pharmaceuticals's earnings date in Invalid Date, Milestone Pharmaceuticals's earnings has grown year over year. MIST earnings in the past year totalled -$41.52 million.

Is Milestone Pharmaceuticals profitable or losing money?

As of the last Milestone Pharmaceuticals earnings report, Milestone Pharmaceuticals is currently losing money. Milestone Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$41.52 million, a 30.44% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.